Skip to main content
. 2020 Dec 14;8(4):763. doi: 10.3390/vaccines8040763

Figure 2.

Figure 2

In vitro replication and hemadsorption of ASFV-SY18-∆CD2v/UK compared to the wild-type ASFV. (A) The in vitro replication kinetics of ASFV-SY18-∆CD2v/UK. The y-axis represents the virus titers recovered at different time points following infection to AM in TCID50/mL on between 0 and 120 h post-infection. The data represent the means from two independent experiments and error bars represent standard deviations of the means. (B) The hemadsorbing activity of ASFV-SY18-∆CD2v/UK and wild-type ASFV in infected cells. Monolayers of AM infected with ASFV-SY18-∆CD2v/UK or wild-type ASFV or non-infected cells (Mock) were shown.